NYSE:IQV - IQVIA Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $246.17
  • Forecasted Upside: 1.59 %
  • Number of Analysts: 16
  • Breakdown:
  • 0 Sell Ratings
  • 1 Hold Ratings
  • 15 Buy Ratings
  • 0 Strong Buy Ratings
▼ -1.67 (-0.68%)

This chart shows the closing price for IQV by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New IQVIA Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for IQV and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for IQV

Analyst Price Target is $246.17
▲ +1.59% Upside Potential
This price target is based on 16 analysts offering 12 month price targets for IQVIA in the last 3 months. The average price target is $246.17, with a high forecast of $273.00 and a low forecast of $156.00. The average price target represents a 1.59% upside from the last price of $242.31.

This chart shows the closing price for IQV for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 16 contributing investment analysts is to buy stock in IQVIA. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart

  • 1 strong buy ratings
  • 15 buy ratings
  • 1 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 17 buy ratings
  • 0 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 15 buy ratings
  • 0 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 17 buy ratings
  • 0 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 16 buy ratings
  • 1 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 14 buy ratings
  • 1 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 15 buy ratings
  • 1 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 15 buy ratings
  • 1 hold ratings
  • 0 sell ratings

Latest Recommendations

  • 0 strong buy ratings
  • 15 buy ratings
  • 1 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
5/14/2021KeyCorpBoost Price TargetOverweight$255.00 ➝ $260.00Medium
5/12/2021Canaccord GenuityBoost Price TargetBuy$220.00 ➝ $260.00Low
5/12/2021ArgusBoost Price TargetBuy$220.00 ➝ $260.00Low
4/26/2021TruistBoost Price Target$235.00 ➝ $260.00Low
4/26/2021Truist SecuritiesBoost Price TargetBuy$235.00 ➝ $260.00Low
4/26/2021Morgan StanleyBoost Price TargetOverweight$220.00 ➝ $260.00Low
4/26/2021BarclaysBoost Price TargetOverweight$235.00 ➝ $260.00Low
4/23/2021Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon RussellBoost Price Target$225.00 ➝ $265.00High
4/23/2021CitigroupBoost Price Target$225.00 ➝ $265.00Low
4/23/2021Jefferies Financial GroupBoost Price TargetBuy$259.00 ➝ $273.00Low
4/23/2021Robert W. BairdBoost Price TargetOutperform$238.00 ➝ $250.00Medium
4/23/2021Deutsche Bank AktiengesellschaftBoost Price TargetBuy$200.00 ➝ $244.00Medium
4/23/2021MizuhoBoost Price TargetBuy$218.00 ➝ $250.00Medium
4/16/2021StephensUpgradeEqual Weight ➝ Overweight$180.00 ➝ $250.00Medium
4/9/2021MizuhoBoost Price TargetBuy$210.00 ➝ $218.00Medium
3/15/2021KeyCorpUpgradeSector Weight ➝ Overweight$218.00High
3/8/2021BarclaysInitiated CoverageOverweight$220.00N/A
3/2/2021BarclaysInitiated CoverageOverweight$220.00Low
2/11/2021TruistBoost Price Target$197.00 ➝ $235.00Low
2/11/2021Wells Fargo & CompanyBoost Price TargetOverweight$205.00 ➝ $230.00Low
2/11/2021Robert W. BairdBoost Price TargetOutperform$208.00 ➝ $221.00Low
2/11/2021Morgan StanleyBoost Price TargetOverweight$205.00 ➝ $220.00Low
2/11/2021MizuhoBoost Price TargetBuy$200.00 ➝ $210.00Low
2/11/2021Piper SandlerBoost Price TargetNeutral$179.00 ➝ $204.00Low
12/18/2020MizuhoBoost Price TargetBuy$190.00 ➝ $200.00Medium
10/22/2020Deutsche Bank AktiengesellschaftBoost Price TargetBuy$180.00 ➝ $196.00Low
10/21/2020UBS GroupBoost Price TargetBuy$204.00 ➝ $224.00Medium
10/21/2020Morgan StanleyBoost Price TargetOverweight$182.00 ➝ $195.00Medium
10/21/2020Piper SandlerBoost Price TargetNeutral$140.00 ➝ $179.00Medium
10/21/2020MizuhoBoost Price TargetBuy$180.00 ➝ $190.00Medium
7/23/2020Robert W. BairdBoost Price TargetOutperform$156.00 ➝ $180.00High
7/23/2020Morgan StanleyBoost Price TargetOverweight$158.00 ➝ $182.00High
7/23/2020Wells Fargo & CompanyBoost Price TargetOverweight$155.00 ➝ $185.00High
7/23/2020Deutsche Bank AktiengesellschaftBoost Price TargetBuy$145.00 ➝ $180.00High
7/23/2020MizuhoBoost Price TargetBuy$153.00 ➝ $180.00High
7/23/2020CitigroupBoost Price TargetBuy$160.00 ➝ $200.00High
7/7/2020Bank of AmericaBoost Price TargetBuy$145.00 ➝ $156.00Medium
7/6/2020StephensInitiated CoverageEqual Weight$150.00Low
4/29/2020SunTrust BanksBoost Price TargetBuy$128.00 ➝ $172.00Medium
4/29/2020Piper SandlerBoost Price Target$115.00 ➝ $138.00High
4/29/2020Stifel NicolausBoost Price TargetBuy$159.00 ➝ $165.00High
4/29/2020Wells Fargo & CompanyBoost Price TargetOverweight$140.00 ➝ $150.00High
4/29/2020Deutsche Bank AktiengesellschaftLower Price TargetBuy$150.00 ➝ $145.00High
4/29/2020CitigroupBoost Price TargetTop Pick ➝ Buy$155.00 ➝ $160.00High
4/28/2020UBS GroupLower Price TargetBuy$200.00 ➝ $162.00High
4/9/2020CitigroupLower Price TargetBuy$195.00 ➝ $155.00Low
4/8/2020Piper SandlerLower Price Target$163.00 ➝ $115.00High
4/6/2020Deutsche Bank AktiengesellschaftLower Price TargetBuy$190.00 ➝ $150.00High
4/3/2020MizuhoLower Price TargetBuy$153.00 ➝ $120.00Medium
4/2/2020Credit Suisse GroupLower Price TargetOutperform$175.00 ➝ $157.00Low
3/31/2020Stifel NicolausLower Price TargetBuy$194.00 ➝ $159.00Low
3/30/2020Wells Fargo & CompanyLower Price TargetOverweight$190.00 ➝ $140.00Low
3/27/2020Morgan StanleyLower Price TargetOverweight$170.00 ➝ $158.00High
3/26/2020BarclaysLower Price TargetOverweight$192.00 ➝ $166.00Low
3/24/2020CfraLower Price TargetBuy$185.00 ➝ $110.00Medium
3/23/2020Jefferies Financial GroupLower Price TargetBuy$195.00 ➝ $127.00High
3/17/2020SunTrust BanksLower Price TargetBuy$184.00 ➝ $128.00Low
3/2/2020Deutsche Bank AktiengesellschaftInitiated CoverageBuy$190.00High
2/13/2020Piper SandlerBoost Price Target$145.00 ➝ $163.00Medium
2/13/2020UBS GroupBoost Price TargetBuy$187.00 ➝ $200.00Low
2/13/2020Robert W. BairdBoost Price TargetOutperform$172.00 ➝ $181.00Low
2/13/2020JPMorgan Chase & Co.Boost Price TargetOverweight$180.00 ➝ $195.00Low
2/13/2020CitigroupBoost Price TargetBuy$185.00 ➝ $195.00Low
2/12/2020Stifel NicolausBoost Price TargetBuy$180.00 ➝ $194.00Low
2/12/2020CfraUpgradeHold ➝ Buy$148.00 ➝ $185.00Low
1/7/2020Wells Fargo & CompanyInitiated CoverageOverweight$180.00Low
1/6/2020CitigroupInitiated CoverageBuy$185.00Medium
12/20/2019Credit Suisse GroupReiterated RatingBuy$170.00N/A
12/13/2019CfraUpgradeSell ➝ HoldLow
11/14/2019Wolfe ResearchUpgradePeer Perform ➝ OutperformLow
7/25/2019Credit Suisse GroupBoost Price TargetOutperform$165.00 ➝ $170.00Low
7/25/2019Wells Fargo & CompanyBoost Price TargetOutperform$170.00 ➝ $178.00Low
7/25/2019JPMorgan Chase & Co.Boost Price TargetOverweight$160.00 ➝ $180.00Low
7/15/2019BarclaysSet Price TargetBuy$180.00Medium
6/27/2019SunTrust BanksBoost Price TargetBuy$155.00 ➝ $175.00Low
6/21/2019MizuhoUpgradeNeutral ➝ Buy$150.00 ➝ $175.00High
6/19/2019MizuhoBoost Price TargetNeutral ➝ Neutral$145.00 ➝ $150.00High
6/19/2019Credit Suisse GroupBoost Price TargetOutperform$159.00 ➝ $165.00High
6/19/2019Morgan StanleyBoost Price TargetOverweight$156.00 ➝ $170.00High
6/19/2019Stifel NicolausBoost Price TargetBuy$167.00 ➝ $178.00High
6/19/2019William BlairReiterated RatingOutperformHigh
5/28/2019SVB LeerinkInitiated CoverageOutperform ➝ Outperform$160.00Low
4/2/2019Wolfe ResearchInitiated CoverageMarket PerformLow
3/18/2019BarclaysBoost Price TargetOverweight ➝ Overweight$160.00 ➝ $167.00Low
2/25/2019ArgusBoost Price TargetBuy ➝ Buy$140.00 ➝ $160.00Low
2/19/2019Wells Fargo & CompanyBoost Price TargetOutperform ➝ Outperform$140.00 ➝ $160.00Low
2/15/2019BarclaysReiterated RatingBuy$155.00Low
2/15/2019UBS GroupSet Price TargetBuy$155.00 ➝ $170.00Low
2/15/2019Piper Jaffray CompaniesBoost Price TargetNeutral$148.00Low
1/18/2019Jefferies Financial GroupUpgradeHold ➝ Buy$136.00 ➝ $150.00High
1/11/2019The Goldman Sachs GroupUpgradeBuy ➝ Conviction-BuyLow
12/3/2018Morgan StanleyBoost Price TargetOverweight ➝ Overweight$130.00 ➝ $145.00High
10/23/2018Royal Bank of CanadaBoost Price TargetOutperform$137.00Low
10/23/2018Piper Jaffray CompaniesBoost Price TargetNeutral$131.00High
10/23/2018BarclaysBoost Price TargetOverweight ➝ Overweight$130.00 ➝ $140.00High
10/9/2018UBS GroupInitiated CoverageBuy ➝ BuyLow
10/2/2018Robert W. BairdBoost Price TargetOutperform ➝ Outperform$143.00 ➝ $146.00Low
8/31/2018Raymond JamesBoost Price TargetStrong-Buy ➝ Strong-Buy$136.00 ➝ $145.00Low
8/23/2018ArgusSet Price TargetBuy$136.00Low
8/13/2018Wells Fargo & CompanyBoost Price TargetOutperform ➝ Outperform$120.00 ➝ $140.00Low
8/6/2018MizuhoSet Price TargetHold$120.00Low
7/25/2018Piper Jaffray CompaniesReiterated RatingHold$97.00High
7/25/2018SunTrust BanksBoost Price TargetBuy$140.00High
7/25/2018Robert W. BairdBoost Price TargetOutperform ➝ Outperform$127.00 ➝ $143.00High
7/25/2018JPMorgan Chase & Co.Boost Price TargetOverweight$135.00High
7/25/2018Morgan StanleyBoost Price TargetOverweight ➝ Overweight$121.00 ➝ $130.00High
7/25/2018BarclaysReiterated RatingOverweight ➝ Overweight$120.00 ➝ $130.00High
7/25/2018Stifel NicolausBoost Price TargetBuy ➝ Buy$128.00 ➝ $150.00High
7/25/2018Royal Bank of CanadaReiterated RatingBuy$129.00High
7/25/2018Bank of AmericaUpgradeNeutral ➝ Buy$135.00High
7/20/2018Jefferies Financial GroupReiterated RatingHold$119.00Low
7/19/2018Royal Bank of CanadaReiterated Rating$110.25$128.00Low
7/3/2018Raymond JamesUpgradeOutperform ➝ Strong-BuyMedium
6/18/2018Robert W. BairdUpgradeNeutral ➝ OutperformHigh
4/13/2018The Goldman Sachs GroupUpgradeNeutral ➝ BuyMedium
4/9/2018ArgusBoost Price TargetBuy ➝ Buy$110.00 ➝ $112.00Low
3/7/2018SunTrust BanksUpgradeHold ➝ BuyLow
2/15/2018Royal Bank of CanadaSet Price TargetBuy$118.00Low
2/15/2018Piper Jaffray CompaniesReiterated RatingHold$103.00Low
2/15/2018JPMorgan Chase & Co.Boost Price TargetOverweight$115.00 ➝ $120.00Low
1/24/2018MizuhoSet Price TargetHold$97.00Low
1/22/2018SunTrust BanksReiterated RatingHold$110.00Low
1/18/2018Evercore ISIInitiated CoverageOutperform ➝ Outperform$112.00High
12/15/2017Mitsubishi UFJ Financial GroupInitiated CoverageNeutral$112.00Low
11/10/2017KeyCorpReiterated RatingOverweight ➝ Sector Weight$100.00N/A
11/9/2017Morgan StanleyBoost Price TargetOverweight$96.00 ➝ $121.00N/A
11/9/2017MizuhoDowngradeBuy ➝ Neutral$90.00N/A
11/3/2017SunTrust BanksReiterated RatingHold$114.00N/A
10/31/2017Credit Suisse GroupReiterated RatingOutperform$115.00 ➝ $125.00N/A
10/30/2017Jefferies Financial GroupBoost Price TargetHold$107.00 ➝ $110.00N/A
10/27/2017BarclaysBoost Price TargetOverweight$100.00 ➝ $120.00N/A
10/27/2017Stifel NicolausUpgradeHold ➝ Buy$92.00 ➝ $128.00N/A
10/16/2017Credit Suisse GroupReiterated RatingOutperform$98.00 ➝ $110.00N/A
10/9/2017Robert W. BairdReiterated RatingHold$98.00N/A
9/24/2017KeyCorpReiterated RatingBuy$100.00Low
9/19/2017Royal Bank of CanadaInitiated CoverageOutperform ➝ Outperform$116.00Low
9/18/2017ArgusBoost Price TargetBuy$98.00 ➝ $104.00Low
8/7/2017CitigroupBoost Price TargetNeutral$96.00 ➝ $97.00Low
8/4/2017Stifel NicolausReiterated RatingHold$87.00 ➝ $92.00Low
8/4/2017Jefferies Financial GroupReiterated RatingHold$94.00Low
8/4/2017BarclaysSet Price TargetBuy$98.00 ➝ $100.00Low
8/4/2017William BlairUpgradeMarket Perform ➝ Outperform$70.10 ➝ $93.42Low
7/17/2017BarclaysReiterated RatingOverweight$90.00 ➝ $98.00Low
7/7/2017Robert W. BairdUpgradeUnderperform ➝ Neutral$76.00 ➝ $93.00Medium
6/28/2017CitigroupReiterated RatingNeutral$87.00 ➝ $96.00Low
6/6/2017Credit Suisse GroupReiterated RatingOutperform$94.00 ➝ $96.00Low
5/15/2017Jefferies Financial GroupBoost Price TargetHold$78.00 ➝ $81.00Low
5/5/2017Jefferies Financial GroupReiterated RatingHold$78.00 ➝ $81.00Low
5/4/2017Evercore ISIReiterated RatingIn-Line$84.00 ➝ $88.50Low
5/4/2017MizuhoBoost Price TargetBuy ➝ Buy$90.00 ➝ $93.00Low
4/3/2017Jefferies Financial GroupReiterated RatingHold$78.00Low
3/31/2017Credit Suisse GroupInitiated CoverageOutperform ➝ Outperform$89.00Low
2/17/2017Wells Fargo & CompanyUpgradeMarket Perform ➝ OutperformN/A
2/15/2017Robert W. BairdDowngradeNeutral ➝ Underperform$80.00 ➝ $74.00N/A
2/3/2017Deutsche Bank AktiengesellschaftDowngradeBuy ➝ Hold$81.00 ➝ $80.00N/A
12/16/2016The Goldman Sachs GroupDowngradeBuy ➝ Neutral$83.00N/A
12/13/2016MizuhoInitiated CoverageNeutral$90.00N/A
12/4/2016Pacific CrestSet Price TargetBuy$82.00N/A
12/2/2016Bank of AmericaDowngradeBuy ➝ Neutral$89.00N/A
12/1/2016Raymond JamesReiterated RatingStrong-Buy ➝ Market PerformN/A
12/1/2016William BlairDowngradeOutperform ➝ Market PerformN/A
12/1/2016CitigroupDowngradeStrong-Buy ➝ Market PerformN/A
11/30/2016BarclaysReiterated RatingOverweight$90.00N/A
10/27/2016Piper Jaffray CompaniesDowngradeOverweight ➝ Neutral$75.00 ➝ $72.00N/A
10/19/2016Jefferies Financial GroupDowngradeBuy ➝ Hold$79.00N/A
10/14/2016Stifel NicolausInitiated CoverageHold$84.00N/A
10/5/2016UBS GroupReiterated RatingBuy$78.00 ➝ $90.00N/A
10/5/2016The Goldman Sachs GroupUpgradeNot Rated ➝ Buy$94.00N/A
8/18/2016ArgusReiterated RatingBuy$75.00 ➝ $85.00N/A
7/28/2016UBS GroupReiterated RatingBuy$78.00N/A
7/28/2016Pacific CrestBoost Price TargetOverweight$75.00 ➝ $82.00N/A
7/28/2016Deutsche Bank AktiengesellschaftBoost Price TargetBuy$71.00 ➝ $81.00N/A
7/28/2016CitigroupBoost Price TargetNeutral$72.00 ➝ $75.00N/A
7/28/2016KeyCorpReiterated RatingBuyN/A
7/27/2016Evercore ISIBoost Price TargetHold$70.00 ➝ $78.00N/A
7/11/2016Avondale PartnersUpgradeMarket Perform ➝ Outperform$62.00 ➝ $87.00N/A
6/28/2016UBS GroupReiterated RatingBuy$78.00N/A
(Data available from 6/23/2016 forward)
IQVIA logo
IQVIA Holdings Inc. provides advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and related implementation services; real world solutions that enable life sciences and provider customers to generate and disseminate evidence, which informs health care decision making and improves patients' outcomes; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services. This segment also provides country level performance metrics related to sales of pharmaceutical products, prescribing trends, medical treatment, and promotional activity across various channels, including retail, hospital, and mail order; and measurement of sales or prescribing activity at the regional, zip code, and individual prescriber level. The Research & Development Solutions segment offers project management and clinical monitoring; clinical trial support; virtual trials; and strategic planning and design services, as well as central laboratory, genomic, bioanalytical, ADME, discovery, and vaccine and biomarker laboratory services. The Contract Sales & Medical Solutions segment provides health care provider and patient engagement services, and scientific strategy and medical affairs services. It serves pharmaceutical, biotechnology, device and diagnostic, and consumer health companies. The company was formerly known as Quintiles IMS Holdings, Inc. and changed its name to IQVIA Holdings Inc. in November 2017. IQVIA Holdings Inc. was founded in 1982 and is headquartered in Durham, North Carolina.
Read More

Today's Range

Now: $242.31
Low: $241.58
High: $244.64

50 Day Range

MA: $234.00
Low: $208.90
High: $246.77

52 Week Range

Now: $242.31
Low: $133.18
High: $248.74


978,652 shs

Average Volume

989,173 shs

Market Capitalization

$46.44 billion

P/E Ratio


Dividend Yield




Frequently Asked Questions

What sell-side analysts currently cover shares of IQVIA?

The following Wall Street analysts have issued reports on IQVIA in the last twelve months: Argus, Bank of America Co., Barclays PLC, Canaccord Genuity, Citigroup Inc., Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon Russell, Deutsche Bank Aktiengesellschaft, Jefferies Financial Group Inc., KeyCorp, Mizuho, Morgan Stanley, Piper Sandler, Robert W. Baird, Stephens, TheStreet, Truist, Truist Securities, UBS Group AG, Wells Fargo & Company, and Zacks Investment Research.
View the latest analyst ratings for IQV.

What is the current price target for IQVIA?

18 Wall Street analysts have set twelve-month price targets for IQVIA in the last year. Their average twelve-month price target is $246.17, suggesting a possible upside of 1.6%. Jefferies Financial Group Inc. has the highest price target set, predicting IQV will reach $273.00 in the next twelve months. Bank of America Co. has the lowest price target set, forecasting a price of $156.00 for IQVIA in the next year.
View the latest price targets for IQV.

What is the current consensus analyst rating for IQVIA?

IQVIA currently has 1 hold rating and 15 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe IQV will outperform the market and that investors should add to their positions of IQVIA.
View the latest ratings for IQV.

What other companies compete with IQVIA?

How do I contact IQVIA's investor relations team?

IQVIA's physical mailing address is 4820 EMPEROR BOULEVARD, DURHAM NC, 27703. The medical research company's listed phone number is 919-998-2000 and its investor relations email address is [email protected] The official website for IQVIA is www.iqvia.com.